Selected presentations and general discussion: Session IX summary and research needs

Medicine & Life Sciences

• Rotenone 95%
• Polychlorinated Biphenyls 82%
• 4-phenyl-1,2,3,6-tetrahydropyridine 62%
• Carbamates 58%
• Dopamine 45%
• Glial Fibrillary Acidic Protein 33%
• NF-kappa B 31%
• Basal Ganglia 30%
• Substantia Nigra 19%
• Vesicular Monoamine Transport Proteins 18%
• Corpus Striatum 17%
• Occupational Groups 17%
• Primates 16%
• Agriculture 13%
• Pesticides 13%
• Occupational Exposure 12%
• Thiocarbamates 11%
• Neurons 11%
• Astrocytes 10%
• Parkinson Disease 10%
• Body Burden 8%
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 7%
• Dopamine Plasma Membrane Transport Proteins 7%
• Putamen 6%
• Parkinsonian Disorders 6%
• Environmental Exposure 6%
• Vimentin 6%
• Single-Photon Emission-Computed Tomography 6%
• Animals 5%
• Wounds and Injuries 5%
• Catecholamines 5%
• Industry 5%
• Serum 5%
• Neuroglia 5%
• Cicatrix 5%
• Regeneration 5%
• Epidemiologic Studies 4%
• Transcription Factors 4%
• Oxidative Stress 4%
• Observation 4%
• Water 3%
• Enzymes 3%
• Health 2%
• Incidence 2%
• Genes 2%
• Proteins 2%

Chemical Compounds

• Rotenone 100%
• Dopamine 50%
• Monoamine 20%
• Tyrosine 16%
• Protein 14%
• Neurological Effect 11%
• Pesticide 11%
• Reduction 10%
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 9%
• Well Water 8%
• Serum Level 8%
• Neurotoxicity 7%
• Catecholamine 6%
• Capacitor 6%
• Oxidative Stress 5%
• Protective 4%
• Industry 4%
• Metabolite 4%
• Additive 4%
• Modification 3%
• Mixture 2%